Studies Find RNA Polymers Factors In Inhibiting Cancerous Cell Growth

Understanding the fundamentals of basic biology can result in new cancer treatments.

A reported study has shown that RNA polymerases, or RNA polymers, have the capabilities of controlling rampant cell growth that’s otherwise known to cause cancer in the body.

Polymerase I and Polymerase II

RNA polymers are essentially enzymes that create RNA based on the genetic code that is found in DNA molecules. The two polyermases, known as polymerase I and polymerase II have similar cellular roles that contribute to the cause with each other instead of interfering with one another’s function. This is a surprising discovery as it leads to a potential exploitation to develop a line of drugs that may control rapid cell growth.

Situational Application

The application of these polymerases within medicine can help control unregulated growth and provide more insight into how the RNA-producing process affect cell growth associated with cancer.

Consider polymerases as chain-building machines. Every chain link that’s created signals a new phase in the transcription process. However, each link requires a series of chemical reactions to occur, which affects the overall chain growth rate. With the application of polymerase I and polymerase II, they can intervene within the altered “chain links” to provide more stability regarding the growth factor.

With a closer look into RNA polymerases and the process of RNA synthesis, there could potentially be more in-depth information in the works for cancer chemotherapy. With a long-term therapeutic agent still in development, there’s still a long road ahead for providing treatment, but better understanding fundamental biological cellular functions is a good first step.


The Midland Certified Reagent Company offers oligos, including dual-labeled probes, for DNA synthesis, RNA Synthesis, and more.